Shabane Barot

Dr. Shabane Barot

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2025 in Annals of Oncology
Verified
Journal Article
Open access
SBShabane Barot
Shabane Barot
ALA. Liljegren
A. Liljegren
CNCaroline Nordenvall
Caroline Nordenvall
JBJ. Blom
J. Blom
CRC. Radkiewicz
C. Radkiewicz
Early-onset colorectal cancer (EOCRC, diagnosis before age 50) is increasing globally. However, survival comparisons with late-onset colorectal cancer (CRC) are inconsistent, and long-term excess mortality remains poorly understood. This Swedish population-based study aimed to evaluate trends in incidence, survival, and long-term excess mortality in early- versus late-onset CRC. We identified all incident colorectal adenocarcinomas recorded in the Swedish National Cancer Register from 1993 to 2019. Incidence trends were quantified using annual percentage changes (APCs) and relative survival differences were assessed using excess mortality rate ratios (EMRRs), both from Poisson regression models with 95% confidence intervals (CIs). A total of 47,864 right-sided colon, 40,664 left-sided colon and 47,082 rectal cancer cases were included. EOCRC patients were more frequently diagnosed with metastatic disease, compared to late-onset CRC. EOCRC incidence increased across all subsites, with APCs ranging from 2.04 (95% CI 1.51-2.56) for rectal to 2.64 (95% CI 2.02-2.37) for right-sided colon cancer, while an increase among late-onset cases was observed only for right-sided colon cancer. Crude 5-year relative survival was similar across age groups, but after full adjustment (including metastatic stage), EOCRC was associated with better survival, with EMRRs ranging from 0.76 (95% CI 0.68-0.84) for rectal cancer to 0.83 (95% CI 0.74-0.92) for right-sided colon cancer. Notably, excess mortality remained elevated 5-10 years post-diagnosis in both age groups. EOCRC incidence is increasing in Sweden, aligning with global trends. Although younger patients were more often diagnosed at an advanced stage of disease, they had similar crude survival and better stage-adjusted survival, compared to older patients. The persistent long-term excess morality in both groups, even during periods when CRC patients are typically considered statistically cured, highlights the need for extended follow-up and tailored survivorship care.

2 October 2023 in Cancer Causes & Control
Verified
Journal Article
Open access
PDF file
SBShabane Barot
Shabane Barot
PRPetri Rantanen
Petri Rantanen
CNCaroline Nordenvall
Caroline Nordenvall
ULUlrik Lindforss
Ulrik Lindforss
ÅEÅsa Hallqvist Everhov
Åsa Hallqvist Everhov
ALAnnelie Liljegren
Annelie Liljegren
Purpose: Colorectal cancer (CRC) risk is associated with modifiable lifestyle factors including smoking, physical inactivity, Western diet, and excess body weight. The impact of lifestyle factors on survival is less known. A cohort study was conducted to investigate the combined effects of a healthy lifestyle and body mass index on prognosis following CRC diagnosis. Methods: Treatment and follow-up data were collected from the patient files of 1098 participants from the Colorectal cancer low-risk study cohort including stage I-III CRC patients. A healthy lifestyle and BMI (HL) score was computed using self-reported data on smoking status, physical activity, adherence to a Mediterranean diet pattern, and BMI, and divided into four categories ranging from least to most healthy. Survival analyses were performed to assess recurrence-free survival and overall survival across categories of exposure, using the Kaplan–Meier method and Cox proportional hazards models adjusted for age, sex, and educational level. Results: Among 1098 participants with stage I-III CRC, 233 (21.2%) had an HL score of 0–1 (least healthy), 354 (32.2%) HL score of 2, 357 (32.5%) HL score of 3 and 154 (14.0) HL score 4 (most healthy). Patients with the healthiest lifestyle (HL score 4) compared to the least healthy (HL score 0–1) had an improved recurrence-free survival (HL 4 vs HL 0–1, HRadj 0.51 (95% CI 0.31–0.83) and overall survival (HL 4 vs HL 0–1, HRadj 0.52 (95% CI 0.38–0.70). Conclusion: Adherence to a healthy lifestyle may increase the recurrence-free and overall survival of patients with stage I–III CRC.

14 November 2024 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
SBShabane Barot
Shabane Barot
LVLitika Vermani
Litika Vermani
JBJohannes Blom
Johannes Blom
SLSusanna Larsson
Susanna Larsson
ALAnnelie Liljegren
Annelie Liljegren
ALAnnika Lindblom
Annika Lindblom
INTRODUCTION: 65%–70% of colorectal cancer (CRC) cases are considered sporadic; they arise under the influence of environmental factors in individuals lacking a family history of CRC. Low-risk genetic variants are believed to contribute to CRC risk, in tandem with lifestyle factors. METHODS: Six hundred sixteen nonfamilial Swedish CRC cases with at least 1 of the following 5 risk factors: smoking, excessive alcohol consumption, physical inactivity, adherence to an unhealthy diet, and excess body weight were included in this study. A control group consisting of 1,642 healthy individuals was used. Cases and controls were genotyped from blood samples at the Centre for Inherited Disease Research at Johns Hopkins University within the Colorectal Transdisciplinary Study research collaboration, using the Illumina Infinium OncoArray-500 K BeadChip. Five separate genome-wide haplotype association analyses were performed, one for each risk factor. Logistic regression models were used to estimate associations between haplotypes (exposure) and CRC (outcome) in cases with lifestyle risk factors vs controls. Haplotypes with an odds ratio >1 were considered candidate risk markers, denoting an area of interest in the genome. A significance threshold of P < 5 × 10−8 was used. RESULTS: We found 17 haplotype regions significantly associated with CRC in cases vs controls. Several regions included genes linked to inflammation and tumor promotion. DISCUSSION: We concluded that having certain genetic variants was associated with an increased risk of CRC compared with healthy controls among cases with known lifestyle risk factors. The interplay of lifestyle and genetic risk factors calls for further elucidation.

4 June 2026 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
SBShabane Barot
Shabane Barot
MAMikael Andersson-Franko
Mikael Andersson-Franko
SGSam Ghazi
Sam Ghazi
ULUlrik Lindforss
Ulrik Lindforss
PRPetri Rantanen
Petri Rantanen
ALAnnelie Liljegren
Annelie Liljegren
Objectives: Tumor budding is an emerging micromorphologic predictor of recurrence in localized colorectal cancer (CRC). Whether its addition to established CRC recurrence risk factors routinely assessed in clinical practice improves prediction accuracy remains unclear. Methods: This study included patients with stage I through III CRC. A detailed micromorphologic assessment was performed for each case according to protocol, using hematoxylin-eosin–stained slides. Clinical characteristics, including treatment and follow-up data, were extracted from patient records. Two logistic regression models were devised to assess recurrence risk, both including established recurrence risk factors chosen a priori. One model also included tumor budding as a dichotomous variable. Receiver operating characteristic curves were used to evaluate and compare the prognostic performance of each model. Results: Of the 1083 cases of CRC included in the study, 441 (41%) displayed tumor budding. Tumor budding was more common in right-sided colon cancer, following a right-to-left gradient in the bowel. It occurred more frequently in patients with adverse prognostic factors and in patients presenting with surgical emergencies necessitating emergency resection. Median follow-up time was 4.3 years. Tumor budding was strongly associated with disease recurrence in univariate analysis, but the association was not maintained in multivariate analysis. There was no statistically significant difference between the areas under the curve of the 2 models. Conclusions: Tumor budding did not substantially contribute to recurrence risk prediction in this study. Further research exploring the association between tumor budding, established recurrence risk factors, and CRC prognosis is warranted.

3 September 2026 in JNCI Cancer Spectrum
Verified
Journal Article
Open access
SBShabane Barot
Shabane Barot
CRCecilia Radkiewicz
Cecilia Radkiewicz
Early-onset colorectal cancer (EOCRC; age <50 years) has increased in high-income countries. We updated a nationwide Swedish cohort study with data from 2020 to 2024 to compare recent trends with those reported during 1993-2019. Using the National Cancer Register, we identified all incident EOCRC at ages 20-49 years. Temporal trends in age-standardized incidence were assessed using segmented Poisson regression with a breakpoint at 2020 to estimate annual percentage changes (APCs). A total of 1616 EOCRC cases were diagnosed during 2020-2024. Annual percentage changes for left-sided colon and rectal cancers were consistent with continued increases in incidence. In contrast, right-sided colon cancer showed a significant change in trend (P = .01), with a nonsignificant decline during 2020-2024 (APC −3.48, 95% CI = −7.88 to 1.14). These findings indicate that the continued rise in EOCRC is primarily driven by distal tumors, that is, left-sided colon and rectal cancers. Continued surveillance is needed to clarify long-term patterns and underlying drivers.

22 October 2025
Verified
Preprint
Open access
PDF file
SBShabane Barot
Shabane Barot
Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cause of cancer-related death. This thesis examines how lifestyle factors affect CRC development and prognosis, the changing CRC incidence and survival trends in Sweden, and the recurrence risk prediction models used to guide adjuvant chemotherapy recommendations.Study I included 1,098 patients diagnosed with stage I-III CRC between 2003 and 2006. The exposure of interest was a healthy lifestyle, and the primary outcome was recurrence-free survival (RFS). Lifestyle data were self-reported using a semi-validated food frequency questionnaire. This data was used to calculate a healthy lifestyle and BMI (HL) score, categorizing participants into four groups, from the healthiest (4 points) to the least healthy (1 point). Follow- up data were collected from patient files, and survival analyses were conducted to assess recurrence-free survival across the four groups, each representing a different category of exposure, with the least healthy group serving as the reference. A healthy lifestyle was associated with a significant improvement in recurrence-free and overall survival.Study II involved 616 cases of sporadic CRC with self-reported lifestyle risk factors and 1,642 healthy controls. Both cases and controls were genotyped using the OncoArray 500 K BeadChip. Five separate sliding-window haplotype GWAS analyses were conducted, all using the same set of healthy controls. Logistic regression was used to estimate the associations between haplotype regions and CRC in cases compared to controls. We identified 17 candidate susceptibility loci that were significantly associated with CRC. Several of these loci contained protein-coding regions of genes involved in inflammation, cell cycle regulation, and cancer development.Study III was a nationwide registry-based study that included 135,610 incident CRC cases diagnosed in Sweden from 1993 to 2019. We used Poisson regression models to quantify incidence trends in early- versus late-onset CRC with annual percentage changes (APCs), and to assess differences in relative survival through excess mortality rate ratios (EMRRs). An increase in EOCRC incidence was observed across the right colon, left colon, and rectum during the study period. Right-sided colon cancer also increased among late-onset patients, while distal colon and rectal cancers decreased in this group starting in 2009. The EOCRC group had better stage-specific relative 5-year survival compared to late-onset patients. However, both groups experienced persistent excess mortality 5-10 years after diagnosis.Study IV included 1,083 cases of stage I-III CRC diagnosed between 2003 and 2006. An experienced pathologist performed a detailed micromorphological assessment for each case according to protocol. Follow-up data were collected from patient files. Two logistic regression models were developed to assess the recurrence risk of cases, one of which included the emerging micromorphological risk factor tumor budding. In univariate analysis, budding was significantly associated with disease recurrence; however, this association was not observed in multivariate regression analyses. The predictive performance of the two models was compared using receiver operating characteristic (ROC) curves. Adding tumor budding to the established risk factors did not improve the prediction of recurrence risk.List of scientific papersI. Barot S; Rantanen P; Nordenvall C; Lindforss U; Everhov AH; Larsson SC; Lindblom A; Liljegren A. Combined associations of a healthy lifestyle and body mass index with colorectal cancer recurrence and survival: a cohort study. Cancer Causes & Control, 2024;35(2): 367-376. https://doi.org/10.1007/s10552-023-01802-yII. Barot S; Vermani L; Blom J; Larsson S; Liljegren A; Lindblom A. Candidate Genetic Loci Modifying the Colorectal Cancer Risk Caused by Lifestyle Risk Factors. Clinical and Translational Gastroenterology, 2025;16(1):e00790. https://doi.org/10.14309/ctg.0000000000000790III. Barot S; Liljegren A; Nordenvall C; Blom J; Radkiewicz C. Incidence trends and long-term survival in early-onset colorectal cancer: a nationwide Swedish study. Annals of Oncology, 2025 ;: SO923- 7534(25)00920-2. https://doi.org/10.1016/j.annonc.2025.07.019IV. Barot S; Andersson-Franko M; Ghazi S; Lindforss U; Rantanen P; Blom J; Lindblom A; Liljegren A. Impact of Tumor Budding on Recurrence Risk Prediction in Stage I-III Colorectal Cancer: A Swedish Cohort study. [Submitted]